[go: up one dir, main page]

DE60131416D1 - Chirale fluorochinolizinon arginine salze - Google Patents

Chirale fluorochinolizinon arginine salze

Info

Publication number
DE60131416D1
DE60131416D1 DE60131416T DE60131416T DE60131416D1 DE 60131416 D1 DE60131416 D1 DE 60131416D1 DE 60131416 T DE60131416 T DE 60131416T DE 60131416 T DE60131416 T DE 60131416T DE 60131416 D1 DE60131416 D1 DE 60131416D1
Authority
DE
Germany
Prior art keywords
arginine salt
fluorochinolicinine
chiral
salt forms
hydroxypiperidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60131416T
Other languages
English (en)
Other versions
DE60131416T2 (de
Inventor
Souza Noel John De
Shiv Kumar Agarwal
Mahesh Vithalbhai Patel
Satish Baliram Bhawsar
Rupinder Kaur Beri
Ravindra Dattatraya Yeole
Nitin Shetty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wockhardt Ltd
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/566,875 external-priority patent/US7247642B2/en
Priority claimed from US09/640,947 external-priority patent/US6750224B1/en
Priority claimed from US09/802,793 external-priority patent/US6514986B2/en
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Application granted granted Critical
Publication of DE60131416D1 publication Critical patent/DE60131416D1/de
Publication of DE60131416T2 publication Critical patent/DE60131416T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60131416T 2000-05-08 2001-05-03 Chirale fluochinolon-argininsalzformen Expired - Fee Related DE60131416T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US09/566,875 US7247642B2 (en) 1999-05-07 2000-05-08 Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
US566875 2000-05-08
US09/640,947 US6750224B1 (en) 1999-05-07 2000-08-17 Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
US640947 2000-08-17
IN0000111 2000-11-22
WOPCT/IN00/00111 2000-11-22
US802793 2001-03-09
US09/802,793 US6514986B2 (en) 2000-11-22 2001-03-09 Chiral fluoroquinolone arginine salt forms
PCT/IN2001/000097 WO2001085095A2 (en) 2000-05-08 2001-05-03 Chiral fluoroquinolizinone arginine salt forms

Publications (2)

Publication Number Publication Date
DE60131416D1 true DE60131416D1 (de) 2007-12-27
DE60131416T2 DE60131416T2 (de) 2008-09-18

Family

ID=56290141

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60131416T Expired - Fee Related DE60131416T2 (de) 2000-05-08 2001-05-03 Chirale fluochinolon-argininsalzformen

Country Status (6)

Country Link
EP (1) EP1311506B1 (de)
AT (1) ATE378335T1 (de)
AU (1) AU7866601A (de)
CA (1) CA2403264A1 (de)
DE (1) DE60131416T2 (de)
WO (1) WO2001085095A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
EP1918289A3 (de) 2002-05-28 2009-08-19 Wockhardt Limited Kristalline Form eines Fluorchinolon-Argininsalzes
WO2003099815A1 (en) * 2002-05-28 2003-12-04 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
US20040176337A1 (en) * 2002-12-31 2004-09-09 Wockhardt Limited Benzoquinolizine-2-carboxylic acid-containing compositions
BR0318460A (pt) 2003-09-04 2006-09-12 Wockhardt Ltd sal de arginina de ácido benzoquinolizina-2-carboxìlico tetrahidratado
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
EP2536408A1 (de) * 2010-02-16 2012-12-26 Wockhardt Research Centre Effluxpumpenhemmer
CN102532131B (zh) * 2010-12-22 2015-09-16 南京长澳医药科技有限公司 一种s-(-)-那氟沙星-l-精氨酸盐的制备方法
WO2013046061A1 (en) * 2011-09-28 2013-04-04 Wockhardt Limited Pures-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,-5h-benzo[i,j]quinolizine-2- carboxylic acid l-arginine salt tetrahydrate and a process for its preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
US7247642B2 (en) * 1999-05-07 2007-07-24 Wockhardt Limited Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment

Also Published As

Publication number Publication date
ATE378335T1 (de) 2007-11-15
DE60131416T2 (de) 2008-09-18
EP1311506B1 (de) 2007-11-14
WO2001085095A2 (en) 2001-11-15
WO2001085095A3 (en) 2002-10-03
WO2001085095B1 (en) 2002-12-27
AU7866601A (en) 2001-11-20
CA2403264A1 (en) 2001-11-15
EP1311506A2 (de) 2003-05-21

Similar Documents

Publication Publication Date Title
MXPA03005464A (es) Agentes antivirales.
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
DE60140814D1 (de) N-phenyl-2-pyrimidine-amine derivatives
BG66094B1 (bg) Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
EP1291362A4 (de) Komplex aus folsäure und polysacchariden, dessen herstellung sowie diesen komplex als aktiven bestandteil enthaltende pharmazeutische zusammensetzung
WO2005000232A3 (en) Six membered amino-amide derivatives as angiogenesis inhibitors
DE60131416D1 (de) Chirale fluorochinolizinon arginine salze
EA200400086A1 (ru) Новые производные оксазолидинонов в качестве антибактериальных агентов
SE0102440D0 (sv) New compound
SE0401655D0 (sv) New compounds
ATE253359T1 (de) Antithrombotische mittel
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
DK1660495T3 (da) Benzoquinolizin-2-carboxylsyreargininsalt,tetrahydrat
DE69927997D1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
DE69828522D1 (de) Antithrombotische mittel
ATE325809T1 (de) Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure
SE9900190D0 (sv) New compounds
PT1411956E (pt) Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih
EP1918289A3 (de) Kristalline Form eines Fluorchinolon-Argininsalzes
DE60008430D1 (de) Verbindungen mit antithrombotischer wirkung
SE0202311D0 (sv) Novel compounds, cytotoxic preparations comprising said compounds, methods of manufacture of said preparations, as well as methods of treatment
DE60208541D1 (de) Antibakterielle mittel
DE60227424D1 (de) Kristalline form eines fluorchinolon-argininsalzes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee